synaptinemal complex in Rhoeo spathacea von McQuade, H.A, Wells, B

Volltext

Radiation effects of thymidine-3H and thymidine-14C von McQuade, H.A., Friedkin, M.

Volltext

Observations on premeiocytes of wheat [Triticum aestivum, morphology] von McQuade, H.A, Young-Rottler, A.M

Volltext

Synaptonemal complexes in premeiotic interphase of pollen mother cells of Triticum aestivum von McQuade, H. A., Bassett, B.

Volltext

Radiation effects of thymidine-2-C 14: II. Chromosome aberrations caused by thymidine-2-C 14 and thymine-2-C 14 in the onion root tip von McQuade, H.A., Friedkin, M., Atchison, Alice A.

Volltext

Radiation effects of thymidine-2-C 14: I. Uptake of thymidine-2-C 14 and thymine-2-C 14 in the onion root tip von McQuade, H.A., Friedkin, M., Atchison, Alice A.

Volltext

The Electron Microscopy of the Response of Follicular Epithelium Cells of Rat Thyroid to Autolysis, Ligation, and Irradiation by Iodine-131 von McQuade, Henry A., Evans, Titus C.

Volltext

1085O Atezolizumab, bevacizumab, and cobimetinib (TACo) in patients (pts) with PD1 refractory melanoma brain metastases (MBM) von Burton, E., Honaker, V., Milton, D., Glitza, I.C., Amaria, R., Patel, S., Diab, A., Wong, M., Mcquade, J., Chung, C., Wefel, J.S., Li, J., Davies, M., Tawbi, H.A.

Volltext

1089P Longitudinal biomarker analysis and outcomes for patients (pts) treated with neoadjuvant nivolumab (nivo) and relatlimab (rela) in surgically resectable melanoma von Burton, E., Wani, K., Milton, D., Lazcano, R., Tetzlaff, M., Ross, M.I., Postow, M.A., Glitza, I.C., Wong, M.K.K., Patel, S., Davies, M., Gershenwald, J.E., Mcquade, J., Prieto, V., Ariyan, C.E., Wargo, J., Tawbi, H.A., Amaria, R.N.

Volltext

1134P Safety and efficacy of low dose (LD) ipilimumab (Ipi) + pembrolizumab (pem) in checkpoint inhibitor (CPI) naïve patients (pts) with melanoma brain metastases (MBM) von Glitza, I.C., Milton, D., Honaker, V., Turner, S., Hennegan, T., Beckham, T., Amaria, R., Patel, S., Diab, A., Wong, M., Mcquade, J., Yee, C., Davies, M., Burton, E., Tawbi, H.A.

Volltext

1094P Relapse free survival (RFS) at 3 years by pathological (path) response to neoadjuvant systemic treatment (NST) in patients (pts) with surgically resectable, high-risk melanom... von Burton, E., Milton, D., Simpson, L., Tetzlaff, M., Glitza, I.C., Ross, M.I., Gershenwald, J.E., Mcquade, J., Wong, M., Patel, S., Diab, A., Postow, M., Ariyan, C.E., Lee, J., Fisher, S., Prieto, V., Davies, M., Tawbi, H.A., Wargo, J., Amaria, R.

Volltext

71MO Clinical and biomarker analyses of intratumoral CD40 agonist sotigalimab in combination with pembrolizumab in metastatic melanoma: A phase I/II trial von Bentebibel, S-E., McGrail, D., Wahab, R. Abdel, Kochat, V., Arslan, E., Pazdrak, B., Tahon, N.H., Amaria, R.N., Glitza, I.C., Patel, S., Wong, M.K.K., Tawbi, H.A., Mcquade, J., Davies, M., Bernatchez, C., Burks, J., Rai, K., Ekmekcioglu, S., Lizée, L., Diab, A.

Volltext

822P Phase II clinical trial: Safety and efficacy study of tocilizumab (Toci) in combination with ipilimumab (Ipi) 3mg/kg plus nivolumab (Nivo) 1mg/kg in patients (pts) with metast... von Abdel-Wahab, N., Montazari, E.J., Spillson, C., Amaria, R., Glitza, I.C., Patel, S., Awiwi, M., Hassan, A., Tahon, N., Elsayes, K.M., Altan, M., Wong, M., Mcquade, J., Tawbi, H.A., Davies, M., Yee, C., Sharma, P., Allison, J., Johnson, D., Diab, A.

Volltext

283MO Leptomeningeal disease (LMD) in patients (pts) with metastatic melanoma (MM): Survival analysis of a contemporary cohort von Glitza, I.C., Saberian, C., Simon, J., Duncan, S., Amaria, R., Davies, M., Diab, A., Mcquade, J., Patel, S., Tawbi, H.A., Yee, C., Wong, M., McCutcheon, I., Milton, D., Ferguson, S.

Volltext

801P Neoadjuvant checkpoint inhibitor immunotherapy (IMT) for resectable mucosal melanoma (MM) von Ho, J.J-Y., Mattei, J., Tetzlaff, M., Williams, M., Davies, M., Diab, A., Glitza, I.C., Mcquade, J., Patel, S., Tawbi, H.A., Wong, M., Yee, C., Fisher, S.B., Hanna, E.Y., Keung, E.Z., Ross, M., Su, S.Y., Faria, S.C., Nagaraja, P., Amaria, R.

Volltext

1085P Ph I/II study of PI3K-β inhibitor GSK2636771 (G771) in combination with pembrolizumab (P) in patients (pts) with PTEN loss and melanoma or other advanced solid tumors von Burton, E., Ileana Dumbrava, E.E., Peng, W., Milton, D., Amaria, R., Mcquade, J., Glitza, I.C., Hong, D., Patel, S., Rodon, J., Yap, T.A., Naing, A., Piha-Paul, S.A., Balmes, G., Lazar, A., Meric-Bernstam, F., Hwu, P., Davies, M.A., Tawbi, H.A.

Volltext

1312PD - Safety and efficacy of TRIplet combination of nivolumab (N) with dabrafenib (D) and trametinib (T) [TRIDeNT] in patients (pts) with BRAF-mutated metastatic melanoma (MM):... von Burton, E.M., Amaria, R.N., Glitza, I.C., Shephard, M., Diab, A., Milton, D., Patel, S., Mcquade, J., Wong, M., Hwu, P., Wargo, J., Davies, M.A., Tawbi, H.A.

Volltext

Safety and efficacy of TRIplet combination of nivolumab (N) with dabrafenib (D) and trametinib (T) [TRIDeNT] in patients (pts) with BRAF-mutated metastatic melanoma (MM): A single... von Burton, E.M., Amaria, R.N., Glitza, I.C., Shephard, M., Diab, A., Milton, D., Patel, S., Mcquade, J., Wong, M., Hwu, P., Wargo, J., Davies, M.A., Tawbi, H.A.

Volltext